Literature DB >> 16377267

Elimination of HIV infection in infants in Europe--challenges and demand for response.

Mikael Ostergren1, Ruslan Malyuta.   

Abstract

Effective interventions for the prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) infection now exist and where these are fully implemented, MTCT rates of 1-2% are achievable. Virtual elimination of HIV in infants by 2010 has therefore been set as a goal for European region. There are, however, many challenges. The eastern European and central Asian countries are facing the fastest growing HIV epidemic in the world with a dramatic increase in numbers of HIV-positive pregnancies and new HIV infected infants. Nevertheless, the prevalence of HIV among pregnant women is still relatively low and the high coverage with antenatal care provide an opportunity to decrease the number of new HIV cases among infants to minimal level. The challenge is to move national strategies for prevention of HIV infection among infants from a disease-focused vertical approach towards effective preventive interventions integrated into mother-child health (MCH) and reproductive health services. The scaling up of prevention interventions among those most at risk and hard-to-reach women are key priority actions. This goes beyond clinical care and needs to include a range of care and protection issues, both in health institutions and in the community. The WHO Regional Office for Europe, together with other UNAIDS co-sponsors, has developed a regional strategic framework for prevention of HIV infection in infants. The strategic framework promotes a comprehensive approach comprising the four interrelated elements: (1) primary prevention of HIV infection; (2) prevention of unintended pregnancies among HIV-infected women; (3) prevention of HIV transmission from HIV-infected women to their children; (4) provision of care and support to HIV-infected women, their infants and families. Implementation of all four pillars of the strategic framework would help European countries to achieve the goal of virtual elimination of HIV infection in infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377267     DOI: 10.1016/j.siny.2005.10.008

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  6 in total

Review 1.  The role of HIV replicative fitness in perinatal transmission of HIV.

Authors:  Xue-Qing Chen; Chang Liu; Xiao-Hong Kong
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

2.  Previous reproductive history and post-natal family planning among HIV-infected women in Ukraine.

Authors:  J Saxton; R Malyuta; I Semenenko; T Pilipenko; R Tereshenko; E Kulakovskaya; I Adejnova; L Kvasha; C Thorne
Journal:  Hum Reprod       Date:  2010-07-19       Impact factor: 6.918

Review 3.  Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges.

Authors:  Steven Nesheim; Lauren Fitz Harris; Margaret Lampe
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

4.  HIV-free survival among nine- to 24-month-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey.

Authors:  Hinda Ruton; Placidie Mugwaneza; Nadine Shema; Alexandre Lyambabaje; Jean de Dieu Bizimana; Landry Tsague; Elevanie Nyankesha; Claire M Wagner; Vincent Mutabazi; Jean Pierre Nyemazi; Sabin Nsanzimana; Corine Karema; Agnes Binagwaho
Journal:  J Int AIDS Soc       Date:  2012-01-30       Impact factor: 5.396

5.  Describing Point of Entry into Care and Being Lost to Program in a Cohort of HIV Positive Pregnant Women in a Large Urban Centre in Uganda.

Authors:  Rachel Musomba; Frank Mubiru; Shadia Nakalema; Hope Mackline; Ivan Kalule; Agnes N Kiragga; Rosalind Parkes Ratanshi; Barbara Castelnuovo
Journal:  AIDS Res Treat       Date:  2017-04-02

6.  Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.

Authors:  Claire Thorne; Igor Semenenko; Tatyana Pilipenko; Ruslan Malyuta
Journal:  BMC Infect Dis       Date:  2009-04-07       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.